Difference between revisions of "Estramustine (Emcyt)"
Jump to navigation
Jump to search
m (Text replace - "package insert<ref name="insert"></ref>." to "prescribing information.<ref name="insert"></ref>") |
(updated content) |
||
| Line 1: | Line 1: | ||
| + | Also known as Estracit. | ||
| + | |||
==General information== | ==General information== | ||
| − | Class/mechanism: Nornitrogen mustard (similar to [[Mechlorethamine (Mustargen)|mechlorethamine]]) linked to estradiol. The estradiol component helps the drug to be preferentially delivered to estrogen receptor-positive cells. The mustard component serves as an alkylator and causes DNA crosslinks. Treatment may result in elevated plasma levels of estradiol.<ref name="insert">[http://www.pfizer.com/files/products/uspi_emcyt.pdf Estramustine (Emcyt) package insert]</ref><ref>[ | + | Class/mechanism: Nornitrogen mustard (similar to [[Mechlorethamine (Mustargen)|mechlorethamine]]) linked to estradiol. The estradiol component helps the drug to be preferentially delivered to estrogen receptor-positive cells. The mustard component serves as an alkylator and causes DNA crosslinks. Treatment may result in elevated plasma levels of estradiol.<ref name="insert">[http://www.pfizer.com/files/products/uspi_emcyt.pdf Estramustine (Emcyt) package insert]</ref><ref>[[Media:Estramustine.pdf | Estramustine (Emcyt) package insert (locally hosted backup)]]</ref> |
<br>Route: PO | <br>Route: PO | ||
<br>Extravasation: n/a | <br>Extravasation: n/a | ||
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [http://online.lexi.com/ Lexicomp], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the prescribing information.<ref name="insert"></ref> | For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [http://online.lexi.com/ Lexicomp], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the prescribing information.<ref name="insert"></ref> | ||
| + | |||
| + | ==Diseases for which it is used== | ||
| + | *[[Prostate cancer]] | ||
==Patient drug information== | ==Patient drug information== | ||
| − | *[http://chemocare.com/ | + | *[http://chemocare.com/chemotherapy/drug-info/estramustine.aspx Estramustine (Emcyt) patient drug information (Chemocare)]<ref>[http://chemocare.com/chemotherapy/drug-info/estramustine.aspx Estramustine (Emcyt) patient drug information (Chemocare)]</ref> |
*[http://www.uptodate.com/contents/estramustine-patient-drug-information Estramustine (Emcyt) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/estramustine-patient-drug-information Estramustine (Emcyt) patient drug information (UpToDate)]</ref> | *[http://www.uptodate.com/contents/estramustine-patient-drug-information Estramustine (Emcyt) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/estramustine-patient-drug-information Estramustine (Emcyt) patient drug information (UpToDate)]</ref> | ||
==References== | ==References== | ||
<references/> | <references/> | ||
| + | |||
| + | [[Category:Drug index]] | ||
| + | [[Category:Chemotherapy]] | ||
| + | [[Category:Nitrogen mustards]] | ||
| + | [[Category:Prostate cancer medications]] | ||
Revision as of 02:36, 31 October 2012
Also known as Estracit.
General information
Class/mechanism: Nornitrogen mustard (similar to mechlorethamine) linked to estradiol. The estradiol component helps the drug to be preferentially delivered to estrogen receptor-positive cells. The mustard component serves as an alkylator and causes DNA crosslinks. Treatment may result in elevated plasma levels of estradiol.[1][2]
Route: PO
Extravasation: n/a
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]
Diseases for which it is used
Patient drug information
- Estramustine (Emcyt) patient drug information (Chemocare)[3]
- Estramustine (Emcyt) patient drug information (UpToDate)[4]